Some aspects of the validity of the Montreal Cognitive Assessment (MoCA)for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
ABSTRACT Background: The Montreal Cognitive Assessment (MoCA) is a short global cognitive scale, and some studies suggest it is useful for evaluating cognition in patients with Parkinson's disease (PD). However, its accuracy has been questioned in studies involving patients with low education....
Main Authors: | Vitor Tumas, Vanderci Borges, Henrique Ballalai-Ferraz, Cyrus P. Zabetian, Ignácio F. Mata, Manuelina M.C. Brito, Maria Paula Foss, Nathalia Novaretti, Bruno Lopes Santos-Lobato |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Neurologia Cognitiva e do Comportamento
|
Series: | Dementia & Neuropsychologia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642016000400333&lng=en&tlng=en |
Similar Items
-
Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised
by: Emmanuelle Sobreira, et al.
Published: (2015-11-01) -
Cognitive deficits in older adults with mild cognitive impairment in a two-year follow-up study
by: Camila de Assis Faria, et al. -
Cluster analysis of cognitive performance in a sample of patients with Parkinson's disease
by: Carolina Pinto Souza, et al. -
Mild cognitive impairment (MCI) and dementia in a sample of adults in the city of Bogotá
by: Olga Lucia Pedraza, et al. -
Montreal Cognitive Assessment (MoCA) no rastreio de comprometimento cognitivo leve (CCL) em pacientes com doença renal crônica (DRC) pré-dialítica
by: Marilise de Andrade Paraizo, et al.
Published: (2016-03-01)